159 related articles for article (PubMed ID: 22538197)
1. Combined use of rapamycin and leflunomide in prevention of acute cardiac allografts rejection in rats.
Sun Y; Chen X; Zhao J; Zou X; Li G; Li X; Shen B; Sun S
Transpl Immunol; 2012 Aug; 27(1):19-24. PubMed ID: 22538197
[TBL] [Abstract][Full Text] [Related]
2. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
3. Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine.
Williams JW; Xiao F; Foster P; Clardy C; McChesney L; Sankary H; Chong AS
Transplantation; 1994 Apr; 57(8):1223-31. PubMed ID: 8178350
[TBL] [Abstract][Full Text] [Related]
4. Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection?
Deuse T; Schrepfer S; Pelletier MP; Fischbein MP; Robbins RC; Reichenspurner H
Transplant Proc; 2007 Mar; 39(2):569-72. PubMed ID: 17362784
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of CTLA-4Ig and sirolimus on orthotopic lung-allograft survival and histology.
Ugurlu MM; Griffin MD; Tazelaar HD; McGregor CG
Transplantation; 2003 Aug; 76(3):489-95. PubMed ID: 12923433
[TBL] [Abstract][Full Text] [Related]
6. Recombinant IL-33 prolongs leflunomide-mediated graft survival by reducing IFN-γ and expanding CD4(+)Foxp3(+) T cells in concordant heart transplantation.
Dai C; Lu FN; Jin N; Yang B; Gao C; Zhao B; Fu JZ; Hong SF; Liang HT; Chen LH; Chen ZS; Chen J; Qi ZQ
Lab Invest; 2016 Aug; 96(8):820-9. PubMed ID: 27295346
[TBL] [Abstract][Full Text] [Related]
7. Leflunomide controls rejection in hamster to rat cardiac xenografts.
Xiao F; Chong AS; Foster P; Sankary H; McChesney L; Koukoulis G; Yang J; Frieders D; Williams JW
Transplantation; 1994 Oct; 58(7):828-34. PubMed ID: 7940718
[TBL] [Abstract][Full Text] [Related]
8. Leflunomide prolongs pulmonary allograft and xenograft survival.
Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice.
Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z
Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187
[TBL] [Abstract][Full Text] [Related]
10. Emodin attenuates acute rejection of liver allografts by inhibiting hepatocellular apoptosis and modulating the Th1/Th2 balance in rats.
Lin SZ; Chen KJ; Tong HF; Jing H; Li H; Zheng SS
Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):790-4. PubMed ID: 20337656
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive effect of combination schedules of brequinar with leflunomide or tacrolimus on rat cardiac allotransplantation.
Antoniou EA; Deroover A; Howie AJ; Chondros K; McMaster P; D'Silva M
Microsurgery; 1999; 19(2):98-102. PubMed ID: 10188834
[TBL] [Abstract][Full Text] [Related]
12. [Combination of CD4+ CD25+ regulatory T cell and costimulatory pathway blockade inhibits acute rejection after liver transplantation: experiment with rats].
Shi LB; Zhang HW; Peng CH
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):942-6. PubMed ID: 17650415
[TBL] [Abstract][Full Text] [Related]
13. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
[TBL] [Abstract][Full Text] [Related]
14. [Expression of regulatory T cells and related cytokines in mice allogenic corneal transplantation rejection].
Wang X; LE QH; Hong JX; Xu JJ; Sun XH; Wang WT; Zhuang H
Zhonghua Yan Ke Za Zhi; 2009 Dec; 45(12):1118-26. PubMed ID: 20193436
[TBL] [Abstract][Full Text] [Related]
15. Renoprotective immunosuppression by pioglitazone with low-dose cyclosporine in rat heart transplantation.
Tanaka Y; Hasegawa T; Chen Z; Okita Y; Okada K
J Thorac Cardiovasc Surg; 2009 Sep; 138(3):744-51. PubMed ID: 19698865
[TBL] [Abstract][Full Text] [Related]
16. Systemic application of sphingosine 1-phosphate receptor 1 immunomodulator inhibits corneal allograft rejection in mice.
Zhu J; Liu Y; Pi Y; Jia L; Wang L; Huang Y
Acta Ophthalmol; 2014 Feb; 92(1):e12-21. PubMed ID: 23910624
[TBL] [Abstract][Full Text] [Related]
17. Antirejection effect of Herba Asari extract in rats after cardiac allograft implantation.
Zhang L; Yu B; Yang B; Zhang G
Transplant Proc; 2009 Dec; 41(10):4328-31. PubMed ID: 20005393
[TBL] [Abstract][Full Text] [Related]
18. Infiltrating CD45RC- T cells are associated with immunologic unresponsiveness induced by donor class I major histocompatibility complex antigens in rats.
Yamaguchi Y; Miyanari N; Ichiguchi O; Akizuki E; Matsumura F; Matsuda T; Okabe K; Liang J; Ohshiro H; Mori K; Ogawa M
Hepatology; 1998 Aug; 28(2):450-8. PubMed ID: 9696011
[TBL] [Abstract][Full Text] [Related]
19. 1 alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts.
Redaelli CA; Wagner M; Tien YH; Mazzucchelli L; Stahel PF; Schilling MK; Dufour JF
Hepatology; 2001 Nov; 34(5):926-34. PubMed ID: 11679963
[TBL] [Abstract][Full Text] [Related]
20. Recipient blood pre-transplant transfusion prolongs hepatic allograft survival in rats.
Wang FS; Yamaguchi Y; Furuhashi T; Uchino S; Kihara S; Yamada S; Mori K; Ogawa M
J Surg Res; 2006 Sep; 135(1):52-60. PubMed ID: 16716354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]